Spevigo Injection
Product Images NDC 0597-0620

Product Visual Gallery

This gallery contains 57 technical images submitted to the FDA as part of the official labeling for Spevigo (NDC 0597-0620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Spevigo 01)

The chart shows the estimated probability of first GPP flare-up over 48 weeks comparing placebo and SPEVIGO injection (600 mg loading dose followed by 300 mg every 4 weeks). The x-axis represents time in weeks from first dose; the y-axis represents estimated flare-up probability. Two survival curves indicate lower flare-up probability with SPEVIGO versus placebo, with numbers of subjects at risk listed below the graph for each time point.*

FDA Label Image

Image (Spevigo 02)

Packaging label for SPEVIGO 300 mg/1 injection, an intravenous human prescription drug. The label shows the product name SPEVIGO prominently, with the strength 300 mg/1 clearly indicated. The labeler is Boehringer Ingelheim Pharmaceuticals, Inc. Additional labeling includes lot number and expiration date areas, and a barcode.*

FDA Label Image

Image (Spevigo 03)

An instructional illustration showing two steps involving a syringe with a plunger and a blue handle. Step 1 and Step 2 are labeled with numbered purple circles next to the syringe in different positions, indicating sequential actions to be performed with the syringe.*

FDA Label Image

Image (Spevigo 04)

An instructional diagram showing a syringe before and after use. Before use, the syringe features labeled parts including thumb pad, plunger rod, finger grip, syringe body, medicine, safety cover, and cap. After use, the diagram shows the needle covered and activated safety cover in place, indicating the needle should be inside the safety cover after use.*

FDA Label Image

Image (Spevigo 05)

An illustration showing a refrigerator with a highlighted section at the top compartment, indicating storage instructions for the medication. The image suggests that the product should be stored in the upper part of a refrigerator.*

FDA Label Image

Image (Spevigo 06)

Illustration showing the contents and items related to SPEVIGO (spesolimab-sbzo) injection. It depicts 2 SPEVIGO prefilled syringes, along with 2 cotton balls or gauze pads, 2 alcohol wipes, and 1 sharps container, noting that cotton balls or gauze, alcohol wipes, and sharps container are not included with the product.*

FDA Label Image

Image (Spevigo 07)

An instructional illustration showing two steps: first, bringing medicine to room temperature for 15 to 30 minutes; second, washing hands under running water with soap. The right side shows hands being washed, and the left side depicts a clock with 15-30 minutes indicated.*

FDA Label Image

Image (Spevigo 08)

An instructional illustration showing a prefilled syringe labeled as containing medicine with a zoomed-in view highlighting the location of the expiration date (EXP YYYY-MMM-DD) on the syringe barrel. The diagram emphasizes checking both prefilled syringes prior to use.*

FDA Label Image

Image (Spevigo 09)

An instructional illustration showing two steps of preparing an injection device. Step 1 highlights the device with a protective cap in place, and Step 2 shows the device after the cap is removed. The device has a blue plunger and a transparent barrel with a needle end.*

FDA Label Image

Image (Spevigo 10)

Illustration showing recommended injection areas for SPEVIGO (spesolimab-sbzo) intravenous injection. The labeled areas include the abdomen and upper thighs, each highlighted with blue circles to indicate proper injection sites on the front view of a human figure.*

FDA Label Image

Image (Spevigo 11)

Illustration showing a hand holding a small packet or wipe, applying it to the skin area marked with concentric circles, likely demonstrating skin preparation or cleaning before injection.*

FDA Label Image

Image (Spevigo 12)

The image contains two prohibition illustrations: the first depicts a hand touching an object with a barred red circle over it, indicating no hand contact; the second shows a profile of a person exhaling with a barred red circle, indicating no breathing or exhaling in the area. These symbols likely convey safety or handling instructions.*

FDA Label Image

Image (Spevigo 13)

An instructional illustration showing a hand holding a syringe with an arrow pointing to a cap, indicating the step of removing the cap from the syringe before use.*

FDA Label Image

Image (Spevigo 14)

Illustration showing a hand with fingers pressing down on a spot marked by a blue circle on an arm, with green arrows indicating the direction of pressure or injection site preparation. The image likely demonstrates a technique related to drug administration or injection site handling.*

FDA Label Image

Image (Spevigo 15)

An instructional illustration showing the correct technique for inserting an injection needle at a 45-degree angle into the skin. The image depicts a hand holding a syringe and an injection site on an arm, highlighting proper needle insertion angle and method.*

FDA Label Image

Image (Spevigo 16)

An instructional diagram showing a hand injecting medicine with a syringe intradermally at a 45-degree angle into the forearm. The image includes the instruction 'Push firmly' and highlights the angle of injection. The diagram is labeled 'B Injecting the medicine.'*

FDA Label Image

Image (Spevigo 17)

Instructional illustration showing a hand administering SPEVIGO injection. The thumb is removed to activate the safety cover at a 45-degree angle, indicating the step for checking that the intravenous injection is complete.*

FDA Label Image

Image (Spevigo 18)

An instructional diagram showing two numbered steps of using a prefilled syringe, likely for intravenous injection. Step 1 shows the syringe with a protective cap on the needle, and Step 2 shows the syringe with the needle exposed after removing the cap, highlighted by a red box. This illustration is associated with SPEVIGO injection by Boehringer Ingelheim Pharmaceuticals, Inc.*

FDA Label Image

Image (Spevigo 19)

An instructional illustration showing the steps to insert two adapters or connectors into the top of a rectangular container. Arrows guide the placement of each part, indicating assembly or connection instructions likely related to medication preparation or infusion equipment.*

FDA Label Image

Image (Spevigo 20)

SPEVIGO (spesolimab-sbzo) injection, intravenous, available in 150 mg/1 mL and 300 mg/1 mL strengths. The label features the Boehringer Ingelheim Pharmaceuticals, Inc. logo and includes essential product identification and dosage form details. The packaging is primarily white with blue accent graphics.*

FDA Label Image

Image (Spevigo 21)

An illustration showing a medical injection device, likely a prefilled syringe or autoinjector, with a plunger and a needle cover. The image depicts a dispensing mechanism used for intravenous administration of medication, consistent with the SPEVIGO (spesolimab-sbzo) injection.*

FDA Label Image

Image (Spevigo 22)

An instructional diagram depicting the components and usage of a syringe before and after use. The 'Before Use' side labels parts including thumb pad, plunger rod, finger grip, medicine, syringe body, safety cover, and cap. The 'After Use' side shows the syringe with activated safety cover and covered needle, emphasizing the needle should be inside the safety cover after use.*

FDA Label Image

Image (Spevigo 23)

An illustration showing a rectangular door or panel with a hinge on the left side and an arrow pointing inward from the left edge, indicating closure or opening direction.*

FDA Label Image

Image (Spevigo 24)

An instructional illustration showing SPEVIGO prefilled syringe alongside items not included in the package: a cotton ball or gauze, an alcohol wipe, and a sharps container. The image depicts these items with labeling to indicate inclusion or exclusion.*

FDA Label Image

Image (Spevigo 25)

An instructional illustration showing two steps: on the left, a clock icon indicating to bring medicine to room temperature for 15 to 30 minutes; on the right, hands being washed under running water with soap.*

FDA Label Image

Image (Spevigo 26)

An instructional diagram showing a prefilled syringe labeled as containing medicine. A magnified inset highlights the expiration date area on the syringe, formatted as EXP YYYY-MMM-DD.*

FDA Label Image

Image (Spevigo 27)

An illustration showing recommended injection areas on the human body for intravenous administration. The diagram highlights the abdomen and upper thighs as suitable sites for injection, each area marked with a blue circle.*

FDA Label Image

Image (Spevigo 28)

An instructional illustration showing a hand using a white wipe to clean or treat a circular, spiral-shaped area on a surface that resembles skin. The spiral design is marked in blue with surrounding segmented green arcs. This image likely depicts a step in the preparation or application process for an intravenous injection or skin treatment related to the product SPEVIGO.*

FDA Label Image

Image (Spevigo 29)

An instructional illustration showing two prohibition symbols. The first symbol depicts a hand wiping a surface inside a red circle with a diagonal line through it, indicating 'no wiping.' The second symbol shows a person exhaling or blowing air, also inside a red circle with a diagonal line, indicating 'no blowing.' These icons likely provide usage or handling warnings.*

FDA Label Image

Image (Spevigo 30)

An instructional illustration showing hands removing the cap from a syringe, presumably preparing an intravenous injection. The syringe features a blue plunger and a clear barrel, and an arrow indicates the direction for cap removal.*

FDA Label Image

Image (Spevigo 31)

An instructional illustration showing a hand pinching the skin with two fingers, highlighting the area with green arrows pointing toward a circular site, likely indicating preparation for an injection or subcutaneous administration.*

FDA Label Image

Image (Spevigo 32)

Illustration showing the technique for inserting a needle at a 45-degree angle during an intravenous injection. The image depicts a hand holding a syringe with a needle, positioned above the injection site on the skin, demonstrating proper injection angle and method.*

FDA Label Image

Image (Spevigo 33)

An instructional illustration showing how to inject a medicine at a 45-degree angle. It depicts one hand holding the syringe and pushing firmly, while the other hand supports the injection site. The image is labeled with the instruction to push firmly and shows the recommended needle angle.*

FDA Label Image

Image (Spevigo 34)

An instructional illustration showing hands demonstrating activation of the safety cover on an injection device. It indicates to remove the thumb to activate the safety cover, with the device held at a 45-degree angle, and a note about checking the injection is complete. This diagram visually guides safe injection handling.*

FDA Label Image

Image (Spevigo 35)

An instructional illustration showing the removal of a cap from a vial or similar container and the insertion of a syringe into the container's opening, indicating how to prepare an injection using the vial.*

FDA Label Image

Image (Spevigo 36)

FDA Label Image

Image (Spevigo 37)

An instructional illustration showing two steps involved in preparing an injection syringe. Step 1 and Step 2 depict adjustment or activation actions on a clear syringe with a blue plunger and a needle cover, likely related to the SPEVIGO intravenous injection process.*

FDA Label Image

Image (Spevigo 38)

Illustration showing the components and use of a syringe for SPEVIGO injection. It labels parts before and after use including thumb pad, plunger rod, finger grip, syringe body, medicine, safety cover, and safety cap. After use, the needle is covered by a safety cover, indicating safe needle handling.*

FDA Label Image

Image (Spevigo 39)

A simple black and white illustration depicting an open container or vial with an arrow pointing towards the bottom section, possibly indicating the direction to open or access the injection vial or container.*

FDA Label Image

Image (Spevigo 40)

An instructional illustration showing components related to SPEVIGO injection: two prefilled syringes, two cotton balls or gauze pads (not included), two alcohol wipes (not included), and one sharps disposal container (not included).*

FDA Label Image

Image (Spevigo 41)

An instructional diagram showing two preparatory steps: allowing medicine to reach room temperature by waiting 15 to 30 minutes, and washing hands thoroughly with soap and water before handling the medication.*

FDA Label Image

Image (Spevigo 42)

An instructional diagram showing a syringe filled with medicine. Labels indicate to check both syringes now and highlight the expiration date format (EXP YYYY-MMM-DD) on the syringe label for verification.*

FDA Label Image

Image (Spevigo 43)

Illustration showing two labeled syringes for the SPEVIGO injection, highlighting the proper components or steps involved in its preparation or administration. The first syringe is highlighted with a red border and numbered 1, the second syringe is labeled 2 without a border.*

FDA Label Image

Image (Spevigo 44)

An illustration showing recommended injection sites for the SPEVIGO injection. Highlighted areas include the abdomen and upper thighs on the human body, indicating these as appropriate locations for intravenous administration of the medication.*

FDA Label Image

Image (Spevigo 45)

An illustration showing a hand applying a small, rounded adhesive patch or medical device onto a skin surface, with colored concentric circles beneath the application site. The image appears to demonstrate the method of applying the product to the skin.*

FDA Label Image

Image (Spevigo 46)

Two instructional icons: the first icon shows a hand touching a box with a red prohibition symbol, indicating not to touch; the second icon shows a person exhaling or blowing with a similar red prohibition symbol, indicating not to breathe or blow on the object. These icons are likely safety or handling precautions.*

FDA Label Image

Image (Spevigo 47)

An instructional diagram showing two hands preparing an injection. One hand is holding the syringe with a blue plunger, while the other hand is pulling off a cap from the syringe needle. A green arrow indicates the direction to remove the cap.*

FDA Label Image

Image (Spevigo 48)

An instructional illustration showing a hand pressing on a circular area on a forearm. Two green arrows indicate the direction of pressure applied by fingers onto the skin, highlighting a site preparation or injection technique.*

FDA Label Image

Image (Spevigo 49)

An instructional illustration showing proper needle insertion technique for an injection. It depicts a hand holding a syringe angled at 45 degrees inserted into the skin of another hand, accompanied by the text 'Inserting the needle.' This diagram visually guides the correct needle angle for injection administration.*

FDA Label Image

Image (Spevigo 50)

An instructional illustration showing a hand injecting medicine intradermally at a 45-degree angle. The image includes a finger pressing firmly on the injection device and an arrow indicating the direction of the push.*

FDA Label Image

Image (Spevigo 51)

Instructional diagram showing how to remove the thumb to activate the safety cover on an injection device. The syringe is held at a 45-degree angle while performing the step, with additional text emphasizing checking that the injection is complete.*

FDA Label Image

Image (Spevigo 52)

An instructional illustration showing two steps for handling a medical device, likely a syringe or injection device. Step 1 depicts the device with a cap/tab on top, with a broader blue handle in the middle. Step 2 shows the same device after the cap has been removed, revealing a needle or tip at the bottom, highlighted by a red outline.*

FDA Label Image

Image (Spevigo 53)

An instructional diagram showing the proper placement of caps and syringes into a sharps disposal container. The image includes arrows indicating inserting syringe barrels into the container and placing caps separately for safe disposal.*

FDA Label Image

Image (Spevigo 54)

FDA Label Image

Principal Display Panel (450 mg/7.5 mL Vial Carton)

Packaging label for Spevigo (spesolimab-sbzo) injection, 450 mg/7.5 mL per vial (60 mg/mL), for intravenous infusion after dilution. The carton contains two single-dose vials, each 450 mg/7.5 mL. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. The label includes usage instructions, NDC 0597-0035-10, a QR code, and barcodes.*

FDA Label Image

Principal Display Panel (150 mg Syringe Carton)

Box packaging label for SPEVIGO (spesolimab-sbzo) Injection, 150 mg/mL per syringe. This prescription drug is indicated for subcutaneous use only and contains two 150 mg single-dose prefilled syringes. The label includes dosing information, illustration of the syringes, and is labeled by Boehringer Ingelheim Pharmaceuticals, Inc.*

FDA Label Image

Principal Display Panel (300 mg/2 mL Syringe Carton)

Packaging label for Spevigo (spesolimab-sbzo) injection, 300 mg/2 mL (150 mg/mL) strength. This single-dose prefilled syringe is for subcutaneous use only. The label includes the Boehringer Ingelheim logo and notes that this carton is to be dispensed as a unit with an enclosed medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.